Refresh

Eris Lifesciences Ltd. - Research Center

540596 ERIS Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

1,330.73 1,215.73 1,108.83 1,020.23 896.54
Expenses

Material consumed

239.62 201.70 202.11 171.56 133.80

Manufacturing expenses

4.41 4.01 3.89 4.54 3.34

Personnel expenses

252.52 222.18 207.02 191.73 166.77

Selling expenses

3.55 6.46 11.22 38.21 35.02

Adminstrative expenses

325.51 297.38 267.27 258.59 223.96

Expenses capitalised

- - - - -

Cost of sales

825.61 731.74 691.52 664.63 562.88

Operating profit

505.11 484.00 417.31 355.60 333.66

Other recurring income

17.26 28.99 10.00 14.73 32.50

Adjusted PBDIT

522.38 512.98 427.31 370.33 366.16

Financial expenses

20.81 2.99 0.78 1.85 22.79

Depreciation

64.66 51.46 37.64 44.88 31.59

Other write offs

- - - - -

Adjusted PBT

436.91 458.54 388.89 323.59 311.78

Tax charges

38.90 41.35 38.29 32.32 26.40

Adjusted PAT

398.01 417.19 350.61 291.27 285.38

Non recurring items

-0.15 -1.01 -1.28 -1.17 -0.10

Other non cash adjustments

- - - - -

Reported net profit

397.86 416.19 349.33 290.10 285.28

Earnigs before appropriation

2,290.14 1,973.93 1,632.42 1,429.11 1,139.01

Equity dividend

99.93 81.65 74.68 30.96 -

Preference dividend

- - - - -

Dividend tax

- - - 8.01 -

Retained earnings

2,190.21 1,892.28 1,557.74 1,390.15 1,139.01
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com